Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php |
Title | 全福生物科技 - BRIM Biotechnology, |
Description | Bringing transformational treatments to patients 全福⽣物科技(全福生技)成立於2013 |
Keywords | N/A |
WebSite | brimbiotech.com |
Host IP | 103.17.8.43 |
Location | Taiwan, Province of China |
Site | Rank |
US$2,297,930
Last updated: 2022-05-16 10:12:59
brimbiotech.com has Semrush global rank of 4,606,018. brimbiotech.com has an estimated worth of US$ 2,297,930, based on its estimated Ads revenue. brimbiotech.com receives approximately 265,146 unique visitors each day. Its web server is located in Taiwan, Province of China, with IP address 103.17.8.43. According to SiteAdvisor, brimbiotech.com is safe to visit. |
Purchase/Sale Value | US$2,297,930 |
Daily Ads Revenue | US$2,122 |
Monthly Ads Revenue | US$63,635 |
Yearly Ads Revenue | US$763,620 |
Daily Unique Visitors | 17,677 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
brimbiotech.com. | A | 295 | IP: 103.17.8.43 |
brimbiotech.com. | NS | 86400 | NS Record: ns25.g-dns.com. |
brimbiotech.com. | NS | 86400 | NS Record: ns26.g-dns.com. |
brimbiotech.com. | MX | 300 | MX Record: 1 aspmx.l.google.com. |
brimbiotech.com. | MX | 300 | MX Record: 5 alt1.aspmx.l.google.com. |
brimbiotech.com. | MX | 300 | MX Record: 5 atl2.aspmx.l.google.com. |
brimbiotech.com. | MX | 300 | MX Record: 10 aspmx4.googlemail.com. |
brimbiotech.com. | MX | 300 | MX Record: 10 aspmx5.googlemail.com. |
brimbiotech.com. | MX | 300 | MX Record: 10 aspmx2.googlemail.com. |
brimbiotech.com. | MX | 300 | MX Record: 10 aspmx3.googlemail.com. |
brimbiotech.com. | TXT | 300 | TXT Record: MS=ms30214353 |
brimbiotech.com. | TXT | 300 | TXT Record: v=spf1 include:_spf.google.com ~all |
brimbiotech.com. | TXT | 300 | TXT Record: v=spf1 +a +mx +ip4:103.17.8.40 include:_spf.eee.tw ~all |
0% 全福生物科技 - BRIM Biotechnology, Inc. 跳至主要內容 首頁 關於全福 關於全福 團隊 董事會成員 營運模式 產品線 產品線 BRM421 – 乾眼症眼藥水 BRM423 – 角膜受損眼藥水 BRM424 – 神經營養性角膜炎 BRM521 – 骨關節炎藥物 新聞 聯絡我們 繁體中文 English 首頁 關於全福 關於全福 團隊 董事會成員 營運模式 產品線 產品線 BRM421 – 乾眼症眼藥水 BRM423 – 角膜受損眼藥水 BRM424 – 神經營養性角膜炎 BRM521 – 骨關節炎藥物 新聞 聯絡我們 繁體中文 English 選單 Bringing transformational treatments to patients sooner 運用整合及高效的 「 轉譯科學 」研發模式 開發直擊病因的新型態治療藥物 我們的產品線 我們結合豐富經驗以及獨特的藥物開發模式,將具潛力的早期標的,快速開發為創新臨床產品。全福的「PEDF衍生之短鏈多胜肽(PEDF-Derived Short Peptide, PDSP)」平台是從人體普遍存在的色素上皮衍生因子(Pigment epithelium-derived factor, PEDF)所衍生而來,可用於數種治療領域以及適應症。 PDSP是一多功能分泌性蛋白,具有抗血管新生,抑制腫瘤、神經營養特性。這項平台可促進多種幹細胞之增生及分化的作用機轉,展現可促進傷口修復以及組織再生的治療潛力。 全球 PDSP 多胜肽平台開發權 全福於2015年完成全球授權合約之簽署自馬偕醫院引進 PDSP 技術,對於角膜受損、骨關節炎、傷口癒合(如燒傷、糖尿病足、肌肉韌帶癒合)、雄性禿,在動物模型已驗證有效。全福是以乾眼症產品進行眼科佈局,進而擴及其他未被滿足之醫療需求疾病。 我們的主要產品 進度最快的乾眼症滴劑治療新藥BRM421,是少數具有早期療效的乾眼症藥物,促進角膜修復之獨特機轉為市場首見(first-in-class),兩次臨床試驗結果顯示具高度安全性,對病人眼睛之乾燥感、灼熱剌痛感、及畏光感均見改善,有機會搶佔第一線用藥市場。全福同時致力於開發數項以促進幹細胞修復為機轉的候選藥物,包括對於嚴重角膜損傷的 BRM423 以及退化性關節炎的 BRM521。 乾眼症眼藥水 |
HTTP/1.1 301 Moved Permanently Server: openresty Date: Tue, 21 Dec 2021 20:54:23 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive X-Redirect-By: WordPress Upgrade: h2,h2c Location: https://www.brimbiotech.com/ Referrer-Policy: no-referrer-when-downgrade |
Domain Name: BRIMBIOTECH.COM Registry Domain ID: 1809002093_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-06-18T02:12:47Z Creation Date: 2013-06-17T15:08:16Z Registry Expiry Date: 2023-06-17T15:08:16Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS25.G-DNS.COM Name Server: NS26.G-DNS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-25T07:48:57Z <<< |